# PROLUNG INC: Form D filings

PROLUNG INC, a biotechnology company in Salt Lake City, UT, filed 6 Form D notices with the SEC between 2015 and 2020. The latest, on December 21, 2020, reports $182,000 sold of a $6 million offering to 4 investors.

Find out what PROLUNG INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20PROLUNG%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=PROLUNG%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fprolung-inc-1541884)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20PROLUNG%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=PROLUNG%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fprolung-inc-1541884)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Utah](https://specstream.ai/data/form-d/state/utah): 660 rows, by operating companies, filed since November 1, 2024, $33, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/utah
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 350 W. 800 N., SUITE 214, Salt Lake City, UT, 84103
- Phone: (801) 736-0729
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1541884

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 21, 2020 | New notice | $6,000,000 | $182,000 | $5,818,000 | 4 | Dec 3, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1541884/000149315220023981/0001493152-20-023981-index.htm) |
| Mar 16, 2018 | New notice | $3,000,000 | $824,000 | $2,176,000 | 4 | Mar 1, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1541884/000149315218003516/0001493152-18-003516-index.htm) |
| May 8, 2017 | Amendment | $8,500,000 | $5,045,370 | $3,454,630 | 160 | Mar 28, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1541884/000108036817000012/0001080368-17-000012-index.htm) |
| Apr 8, 2016 | New notice | $5,250,000 | $516,055 | $4,733,945 | 11 | Mar 28, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1541884/000108036816000035/0001080368-16-000035-index.htm) |
| Nov 23, 2015 | New notice | $1,256,931 | $1,256,931 | $0 | 2 | Nov 9, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1541884/000108036815000023/0001080368-15-000023-index.htm) |
| Feb 27, 2015 | New notice | $1,000,000 | $0 | $1,000,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1541884/000108036815000007/0001080368-15-000007-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Garff Michael | Executive Officer, Director |  |
| Jared Bauer | Executive Officer |  |
| Don Patterson | Director |  |
| Jim Hogan | Director |  |
| David Nielsen | Director |  |

## Other biotechnology companies in Utah that filed recently

- [Life Impact Partners 14 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-14-llc-2163022) offering · Nov 9, 2026
- [Life Impact Partners 15 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-15-llc-2163019) offering · Nov 9, 2026
- [Life Impact Partners 7 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-7-llc-2163024) offering · Nov 6, 2026
- [Life Impact Partners 6 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-6-llc-2163017) offering · Nov 6, 2026
- [Life Impact Partners 3 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-3-llc-2162995) offering · Nov 6, 2026
- [Life Impact Partners 5 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-5-llc-2162994) offering · Nov 6, 2026
- [Life Impact Partners 4 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-4-llc-2162993) offering · Nov 6, 2026
- [Life Impact Partners 2 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-2-llc-2162992) offering · Nov 6, 2026
- [Life Impact Partners 8 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-8-llc-2162973) offering · Nov 6, 2026
- [Life Impact Partners 1 LLC](https://specstream.ai/data/form-d/company/life-impact-partners-1-llc-2154209) offering · Oct 22, 2026
- [3Helix, Inc.](https://specstream.ai/data/form-d/company/3helix-inc-2001622) $7.8 million · Sep 21, 2026
- [Halia Therapeutics, Inc.](https://specstream.ai/data/form-d/company/halia-therapeutics-inc-1829255) $3.5 million · Aug 31, 2026
- [Paterna BioSciences HoldCo Inc.](https://specstream.ai/data/form-d/company/paterna-biosciences-holdco-inc-1989862) $6.3 million · Aug 12, 2026

[Every Form D from the week of Dec 21, 2020](https://specstream.ai/data/form-d/week/2020-12-21) · [All recent filings in Utah](https://specstream.ai/data/form-d/state/utah) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what PROLUNG INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).